Diabetes and Chronic Kidney Disease
This JAMA Insights discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes.
This JAMA Insights discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes.
A 14-year old girl presents with sudden painless vision decline in the left eye for 5 days and reports constant fatigue, occasional dizziness, mild pain in the lower limbs, and intermittent claudication over the past 12 months with no history…
Importance Molecular techniques, including next-generation sequencing, genomic copy number profiling, fusion transcript detection, and genomic DNA methylation arrays, are now indispensable tools for the workup of central nervous system (CNS) tumors. Yet there remains a great deal of heterogeneity in using…
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to improve practices around brain health preservation and prevention of cognitive decline.
As the health care landscape evolves, we face significant challenges in maintaining an adequate supply of well-trained health care professionals to meet the demands of our diverse population. Key topics include the impact of demographic shifts, technological advancements, and policy…
This online activity is designed to help primary care physicians and other providers better understand the options for colorectal cancer screening and increase confidence in the use of FOBT/FIT as an effective screening modality. The activity provides a review of…
This article describes historical and political reasons for and devastating consequences of US opioid prescribing policy since the 1990s, which has restricted opioid prescribing for pain less than for treating opioid use disorder (OUD) treatment. This article considers merits and…
Structural determinants of health frameworks must express anti-racism to be effective, but racial and ethnic inequities are widely documented, even in harm reduction programs that focus on person-centered interventions. Harm reduction strategies should express social justice and health equity, resist…
Severe opioid withdrawal, risk of patient-initiated discharge, and some inpatients’ use of unregulated substances prompt clinical and ethical questions considered in this commentary on a case. Short-acting opioids can be used to manage inpatients’ pain and opioid use disorder (OUD)…
Practices and interventions that aim to slow progression or reduce negative consequences of substance use are harm reduction strategies. Often described as a form of tertiary prevention, harm reduction is key to caring well for people who use drugs. Evidence-based…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org